The G-protein coupled receptor family represents a large number of neurotransmitter receptors. Among the diverse signal transduction pathways mediated via G-proteins, phospholipase C mediated phosphatidylinositol hydrolysis represents one of the best characterized signal transduction mechanisms. Accordingly, the measurement of agonist-induced phosphatidylinositol turnover has been used as a convenient functional assay for receptor activation. Assays currently used for this purpose, however, are not suitable for high throughput screening. In this article, an improved technique using 96-well microtiter plate format for measuring phosphatidylinositol turnover is introduced. Anion exchange columns were prepared on fiber glass 96-well multiscreen filter plate. Separation and detection of released inositol phosphates were conducted in a 96-well format. Cells expressing certain neurotransmitter receptors were challenged with agonists and the receptor-mediated PI turnover was measured by the new technique and the results obtained were compared to that obtained from traditional assays. The results indicate that the 96-well assay is 10 to 20 times more efficient than the traditional method and is, furthermore, suitable for high throughput drug screening. Our data also indicate that this method is particularly useful for characterizing multiple antagonists by Schild analysis.
References
1.
Berridge, M. J., Dawson, R. M. C., Downes, C. P., Heslop, J. P., Irvine, R. F. (1983). Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem. J.212:473-482.
2.
Berridge, M. J., Irvine, R. F. (1984). Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature312:315-321.
3.
Martin, T. F. J. (1993). Receptor regulation of phosphoinositidase C. In Intracellular messengers. ed. Taylor, C. W. pp. 63-87: Pergamon Press, New York.
4.
Oldham, K. G. (1990). Polyphosphoinositide turnover. In Receptor-effector coupling—A practical approach. ed. Hulme, E.C. pp. 99-116: Oxford University Press.
5.
Heuillet, E., Menager, J., Fardin, V., Flamand, O., Bock, M., Garret, C., Crespo, A., Fallourd, A. M., Doble, A. (1993). Characterization of a human NKl tachykinin receptor in the astrocytoma cell line U 373 MG. J. Neurochem.60:868-876.
6.
Krause, J. E., Blount, P., Sachais, B. S. (1994). Molecular biology of receptors, structures, expression, and regulatory mechanisms. In The receptors. ed. Bylund, D. B. pp. 165-218. University of Nebraska Med Ctr, Omaha, NE: Humana Press.
7.
Mantyh, P. W., Pinnock, R. D., Downes, C. P., Goedert, M., Hunt, S. P. (1984). Correlation between inositol phospholipid hydrolysis and substance P receptors in rat CNS. Nature309:795-797.
8.
Chung, F. Z., Wu, L. H., Vartanian, M. A., Watling, K. J., Guard, S., Woodruff, G. N., Oxender, D. L. (1994). The non-peptide tachykinin NK2 receptor antagonist SR 48968 interacts with human, but not rat, cloned tachykinin NK3 receptors. Biochem. Biophys. Res. Commun.198:967-972.
9.
Tian, Y., Wu, L. H., Pu, Y. M., Huang, C. C., Chung, F. Z. (1996b). Structural motifs encoded by individual exons of the human neurokinin-1 receptor gene interact differentially with selective agonists and antagonists. J. Neurochem.67:1191-1199.
10.
Tian, Y., Wu, L. H., Oxender, D. L., Chung, F. Z. (1996a). The unpredicted high affinities of a large number of naturally occurring tachykinins for chimerie NK1/NK3 receptors suggest a role for an inhibitory domain in determining receptor specificity. J. Biol. Chem.271:20250-20257.
11.
Jenkinson, S., Nahorski, S. R., Challiss, R. A. J. (1994). Disruption by lithium of phosphatidylinositol-4,5-bisphosphate supply and inositol-1,4,5-trisphosphate generation in Chinese hamster ovary cells expressing human recombinant m(l) muscarinic receptors. Mol. Pharmacol.46:1138-1148.
12.
Croci, T., Landi, M., Emondsalt, X., Lefur, G., Manara, L. (1995). Neuronal NK3-receptors in guinea-pig ileum and taenia caeci: In vitro characterization by their first non-peptide antagonist, SR142801. Life Sci.57:PL361-PL366.
13.
Patacchini, R., Bartho, L., Holzer, P., Maggi, C. A. (1995). Activity of SR 142801 at peripheral tachykinin receptors. Eru. J. Pharmacol.278:17-25.
14.
Chung, F. Z., Wu, L. H., Tian, Y., Vartanian, M. A., Lee, H., Bikker, J., Humblest, C., Pritchard, M. C., Raphy, J., Sumanchauhan, N., Horwell, D. C., Lalwani, N. D., Oxender, D. L. (1995). Two classes of structurally different antagonists display similar species preference for the human tachykinin neurokinin(3) receptor. Mol. Pharmacol.48:711-716.
